This is a community-generated profile. If you would like to claim it, please .
OptiNose Funding
$48.5M
22 rounds
OptiNose is active in the following markets / industries: biotechnology. The company has secured funding across 2 rounds, totaling in an amount of $48.5M. Their most recent funding was raised on August 5, 2014.
Investors of OptiNose
Bodil Arlander
20 years of investing experience. Served on 11 for profit boards, including 2 NYSE companies. Experience covers strategy, business development, and finance.
WFD Ventures
Fidelity Management and Research Company
Entrepreneurs Fund
Avista Capital Partners
Rounds
C
U